
Aster DM Healthcare (ASTERDM) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
10.8B
Gross Profit
8.3B
77.07%
Operating Income
1.4B
13.37%
Net Income
935.6M
8.68%
EPS (Diluted)
₹1.67
Balance Sheet Metrics
Total Assets
66.1B
Total Liabilities
29.5B
Shareholders Equity
36.5B
Debt to Equity
0.81
Cash Flow Metrics
Revenue & Profitability Trend
Aster DM Healthcare Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 41.4B | 36.4B | 29.5B | 102.5B | 85.2B |
Cost of Goods Sold | 9.4B | 9.2B | 7.8B | 28.9B | 25.7B |
Gross Profit | 32.0B | 27.3B | 21.7B | 73.6B | 59.5B |
Gross Margin % | 77.3% | 74.9% | 73.4% | 71.8% | 69.8% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 9.2B | 9.9B | 7.7B | 8.1B | 8.4B |
Other Operating Expenses | 7.5B | 4.7B | 4.1B | 18.0B | 12.4B |
Total Operating Expenses | 16.8B | 14.6B | 11.8B | 26.1B | 20.8B |
Operating Income | 5.2B | 3.7B | 2.7B | 8.4B | 5.0B |
Operating Margin % | 12.5% | 10.1% | 9.0% | 8.2% | 5.9% |
Non-Operating Items | |||||
Interest Income | - | 47.8M | 48.6M | 48.0M | 42.0M |
Interest Expense | 1.2B | 1.1B | 851.5M | 2.6B | 2.9B |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 4.7B | 2.6B | 2.0B | 6.4B | 2.1B |
Income Tax | 1.3B | 565.1M | 358.7M | 358.0M | 272.2M |
Effective Tax Rate % | 28.5% | 21.6% | 18.4% | 5.6% | 13.3% |
Net Income | 54.1B | 2.1B | 4.8B | 6.0B | 1.8B |
Net Margin % | 130.7% | 5.8% | 16.1% | 5.9% | 2.1% |
Key Metrics | |||||
EBITDA | 9.0B | 13.5B | 10.6B | 15.3B | 11.3B |
EPS (Basic) | ₹107.98 | ₹2.60 | ₹8.54 | ₹10.58 | ₹2.97 |
EPS (Diluted) | ₹107.85 | ₹2.60 | ₹8.53 | ₹10.57 | ₹2.97 |
Basic Shares Outstanding | 498039452 | 497500000 | 497300000 | 497155009 | 496900000 |
Diluted Shares Outstanding | 498039452 | 497500000 | 497300000 | 497155009 | 496900000 |
Income Statement Trend
Aster DM Healthcare Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 1.6B | 822.3M | 3.8B | 3.4B | 2.6B |
Short-term Investments | 13.3B | 283.4M | 589.9M | 780.6M | 565.3M |
Accounts Receivable | 2.6B | 2.3B | 23.4B | 20.2B | 20.2B |
Inventory | 923.5M | 1.1B | 13.1B | 10.3B | 8.5B |
Other Current Assets | 537.0M | 31.7M | 2.9B | 5.0B | 3.5B |
Total Current Assets | 19.0B | 141.7B | 49.2B | 41.0B | 36.3B |
Non-Current Assets | |||||
Property, Plant & Equipment | 36.3B | 11.5B | 22.9B | 19.7B | 18.4B |
Goodwill | 5.6B | 5.6B | 26.9B | 24.5B | 23.5B |
Intangible Assets | 303.2M | 313.7M | 3.7B | 2.8B | 2.5B |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 571.1M | 500.0K | 1.1B | 746.2M | 352.2M |
Total Non-Current Assets | 47.0B | 38.3B | 99.6B | 84.5B | 80.1B |
Total Assets | 66.1B | 179.9B | 148.8B | 125.5B | 116.4B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 4.3B | 4.6B | 29.9B | 21.2B | 20.3B |
Short-term Debt | 1.9B | 2.5B | 12.3B | 9.7B | 7.7B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 711.7M | 18.5M | 138.6M | 201.8M | 109.5M |
Total Current Liabilities | 8.8B | 112.9B | 46.6B | 35.6B | 32.0B |
Non-Current Liabilities | |||||
Long-term Debt | 18.3B | 11.4B | 44.7B | 39.4B | 40.3B |
Deferred Tax Liabilities | 1.5B | 2.5B | 2.4B | 1.7B | 1.5B |
Other Non-Current Liabilities | 525.7M | 491.0M | 6.2M | 261.9M | 302.4M |
Total Non-Current Liabilities | 20.8B | 16.7B | 53.7B | 45.1B | 46.1B |
Total Liabilities | 29.5B | 129.6B | 100.2B | 80.6B | 78.1B |
Equity | |||||
Common Stock | 5.0B | 5.0B | 5.0B | 5.0B | 5.0B |
Retained Earnings | - | 4.9B | 4.2B | 4.1B | -990.6M |
Treasury Stock | - | 109.7M | 134.9M | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 36.5B | 50.3B | 48.6B | 44.8B | 38.3B |
Key Metrics | |||||
Total Debt | 20.2B | 13.8B | 57.0B | 49.1B | 48.0B |
Working Capital | 10.2B | 28.8B | 2.7B | 5.4B | 4.3B |
Balance Sheet Composition
Aster DM Healthcare Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 55.4B | 3.3B | 5.4B | 6.4B | 2.1B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 84.2M | 73.6M | 6.7M | -1.3M | 24.9M |
Working Capital Changes | -1.4B | -16.7B | 878.8M | -4.0B | 2.0B |
Operating Cash Flow | 54.1B | -9.3B | 9.5B | 4.9B | 6.9B |
Investing Activities | |||||
Capital Expenditures | -3.4B | -7.5B | -7.1B | -4.8B | -3.7B |
Acquisitions | 74.9B | -1.4B | -1.3B | -472.6M | 654.1M |
Investment Purchases | -11.9B | - | -46.1M | - | -125.3M |
Investment Sales | 84.6M | 82.1M | 3.1M | 174.9M | - |
Investing Cash Flow | 59.6B | -8.8B | -8.4B | -5.1B | -3.1B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -61.7B | - | - | - | - |
Debt Issuance | 1.9B | - | 3.6B | 673.8M | 1.9B |
Debt Repayment | -1.3B | - | -6.0B | -3.7B | -5.6B |
Financing Cash Flow | -61.8B | 2.5B | -2.0B | -2.1B | -6.2B |
Free Cash Flow | 683.2M | -6.5B | 9.9B | 7.7B | 11.5B |
Net Change in Cash | 51.9B | -15.6B | -884.1M | -2.3B | -2.4B |
Cash Flow Trend
Aster DM Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
92.34
Forward P/E
62.11
Price to Book
8.47
Price to Sales
7.17
PEG Ratio
62.11
Profitability Ratios
Profit Margin
7.55%
Operating Margin
13.37%
Return on Equity
147.28%
Return on Assets
81.40%
Financial Health
Current Ratio
2.16
Debt to Equity
55.26
Beta
0.06
Per Share Data
EPS (TTM)
₹6.33
Book Value per Share
₹68.98
Revenue per Share
₹84.02
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
asterdm | 302.1B | 92.34 | 8.47 | 147.28% | 7.55% | 55.26 |
Max Healthcare | 1.2T | 115.26 | 13.09 | 12.10% | 15.31% | 32.09 |
Apollo Hospitals | 1.0T | 72.09 | 12.70 | 18.85% | 6.63% | 90.89 |
Fortis Healthcare | 677.5B | 78.10 | 7.60 | 8.44% | 10.73% | 26.99 |
Global Health | 372.6B | 69.59 | 11.01 | 15.30% | 13.04% | 21.19 |
Narayana Hrudayalaya | 358.6B | 45.78 | 9.89 | 21.78% | 13.82% | 66.93 |
Financial data is updated regularly. All figures are in the company's reporting currency.